Superpower has launched Specialty Panels, add-on blood biomarker test bundles that provide targeted insights into specific health domains including fertility, cardiovascular health, metabolism, immunity, nutrient status, and methylation.
The Fertility Panel is priced at $159 in most US states and $229 in New York and New Jersey. The panel provides fertility insights including overlooked biomarkers that can inform reproductive health decisions years before conception attempts. One in five women in the United States struggles with infertility, and nearly 50% of adults live with a preventable chronic condition that earlier detection could address.
The US company raised $30 million in Series A funding earlier in 2025 and acquired Feminade, a women’s health testing platform focused on hormonal health and functional medicine, in January 2025. The acquisition brought Feminade’s expertise in women’s hormonal testing and community into Superpower’s platform.
Superpower’s platform connects with wearables including Oura and Whoop and offers over 100 lab tests. The specialty panels allow members to access curated, discounted biomarker packages aligned with personal health goals rather than ordering individual tests.
